Recent Quotes
My Watchlist
Indicators
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Celcuity Inc. - Common Stock (NQ:CELC)

115.76 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EDT, Mar 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6
Open 115.76
Bid (Size) 108.00 (4,000)
Ask (Size) 185.21 (200)
Prev. Close 115.76
Today's Range 115.76 - 115.76
52wk Range 7.575 - 120.31
Shares Outstanding 46,271,259
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Apis Capital Trims Holdings of Celcuity Stock, According to Recent SEC Filing ↗
Celcuity develops targeted cancer therapies and diagnostics, leveraging proprietary technology and strategic licensing in oncology. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Manager Closes Position in GEO Stock, Sells $17.6 Million Worth of Shares, According to Recent SEC Filing ↗
This corrections firm delivers facility management and reentry services to government clients in the U.S., Australia, and South Africa. 
Via The Motley Fool
Topics Immigration Regulatory Compliance

Performance

YTD
+15.1%
+15.1%
1 Month
+7.3%
+7.3%
3 Month
+13.7%
+13.7%
6 Month
+107.0%
+107.0%
1 Year
+1019.5%
+1019.5%

More News

Read More
News headline image
Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In ↗
Via The Motley Fool
News headline image
Earnings Scheduled For November 12, 2025 ↗
Via Benzinga
News headline image
Exploring Celcuity's Earnings Expectations ↗
Via Benzinga
News headline image
Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The Great Rotation of 2026: Why Small-Cap 'Underdogs' are Finally Outpacing the Tech Titans
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
Apis Capital Expands Garrett Motion Stake as Hybrid Demand Extends the Combustion Cycle ↗
Via The Motley Fool
Topics Economy Emissions Regulatory Compliance
News headline image
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗
Via The Motley Fool
News headline image
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Soleus Adds a Significant Number of Celcuity Shares ↗
Via The Motley Fool
Director Sells 20,000 Celcuity Shares for $2.4 Million Following 933% Share Price Jump ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
From Equity Insider
Via GlobeNewswire
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
3 Stocks You’ll Wish You Bought Before 2026 ↗
Via MarketBeat
News headline image
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
GEO Shares Down 44% as Fund Sells $9 Million in Stock Amid ICE Allegations and Softer Outlook ↗
Via The Motley Fool
Topics Immigration Regulatory Compliance
News headline image
Celcuity Analyst No Longer Bullish Despite Breast Cancer Therapy Application ↗
Via Benzinga
News headline image
CELCUITY INC (NASDAQ:CELC) Stock Surges 70% in a Month Following Q3 Earnings Beat and Positive Clinical Data ↗
Via Chartmill
Topics Earnings

Frequently Asked Questions

Is Celcuity Inc. - Common Stock publicly traded?
Yes, Celcuity Inc. - Common Stock is publicly traded.
What exchange does Celcuity Inc. - Common Stock trade on?
Celcuity Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Celcuity Inc. - Common Stock?
The ticker symbol for Celcuity Inc. - Common Stock is CELC on the Nasdaq Stock Market
What is the current price of Celcuity Inc. - Common Stock?
The current price of Celcuity Inc. - Common Stock is 115.76
When was Celcuity Inc. - Common Stock last traded?
The last trade of Celcuity Inc. - Common Stock was at 03/11/26 04:15 PM ET
What is the market capitalization of Celcuity Inc. - Common Stock?
The market capitalization of Celcuity Inc. - Common Stock is 5.36B
How many shares of Celcuity Inc. - Common Stock are outstanding?
Celcuity Inc. - Common Stock has 5B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>